CLLKF 股利： BICO Group AB (publ) 收益洞察

Q: BICO Group AB (publ) 的關鍵財務報表是什麼？

根據最新的財務報表（Form-10K），BICO Group AB (publ) 的總資產為 $5,483，淨isProfitable}為 $-5

Q: CLLKF 的關鍵財務比率是什麼？

BICO Group AB (publ) 的流動比率為 2.19，淨利潤率為 -0.25，每股銷售為 $27.57。

Q: BICO Group AB (publ) 的收入按細分市場或地理位置如何劃分？

BICO Group AB (publ) 最大收入來源為 Life Science Solutions，在最近的收益報告中收入為 1,009,100,000。就地區而言，United States 是 BICO Group AB (publ) 的主要市場，收入為 1,162,800,000。

Q: BICO Group AB (publ) 是否盈利？

無，根據最新的財務報表，BICO Group AB (publ) 的淨損失為 $-5

Q: BICO Group AB (publ) 有負債嗎？

是的，BICO Group AB (publ) 的負債為 2,498

Q: BICO Group AB (publ) 的流通股有多少？

BICO Group AB (publ) 的總流通股為 70.57

首頁

股票

CLLKF

CLLKF 財務

BICO Group AB (publ)

收盤價：Jan 26, 16:00:00 GMT-5

盤後：Jan 26, 17:32:57 GMT-5

概觀預測收益股利財務狀況

收入

資產負債表

現金流量

年度

每季

CLLKF 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
營收	1,506	1,946	2,010	2,120	1,257	416
營收年增率 (YoY)	-30%	-3%	-5%	69%	202%	136%
營收成本	950	939	1,017	1,031	688	199
毛利	556	1,007	993	1,089	569	216
銷售、一般及管理費用	465	795	831	1,162	669	230
研發	102	165	227	--	--	--
營業費用	782	1,289	1,112	1,364	806	268
其他非營業收入 (費用)	0	0	-3	-10	-5	--
稅前淨利	-1,258	-70	-797	-34	-213	-54
所得稅費用	4	23	-8	53	15	-5
淨利	-683	-5	-1,172	-832	-227	-48
淨利成長	-45%	-100%	41%	267%	373%	-23%
稀釋後流通股數	70.57	70.57	70.57	64.34	57.26	43.85
股數年變動 (YoY)	0%	0%	10%	12%	31%	4%
每股盈餘 (稀釋)	-9.67	-0.07	-16.61	-12.94	-3.97	-1.09
每股盈餘成長率	-45%	-100%	28%	225.99%	262%	-25%
自由現金流	159	72	-112	-799	-676	-213
每股自由現金流	--	--	--	--	--	--
毛利率	36.91%	51.74%	49.4%	51.36%	45.26%	51.92%
營業利益率	-15%	-14.49%	-5.92%	-12.92%	-18.77%	-12.25%
淨利率	-45.35%	-0.25%	-58.3%	-39.24%	-18.05%	-11.53%
自由現金流利潤率	10.55%	3.69%	-5.57%	-37.68%	-53.77%	-51.2%
EBITDA	-1	196	1,810	666	-45	1
EBITDA 利潤率	-0.06%	10.07%	90.04%	31.41%	-3.57%	0.24%
EBITDA 中的折舊與攤銷	225	478	1,929	940	191	52
EBIT	-226	-282	-119	-274	-236	-51
EBIT 利潤率	-15%	-14.49%	-5.92%	-12.92%	-18.77%	-12.25%
有效稅率	-0.31%	-32.85%	1%	-155.88%	-7.04%	9.25%

Follow-Up Questions

BICO Group AB (publ) 的關鍵財務報表是什麼？



CLLKF 的關鍵財務比率是什麼？



BICO Group AB (publ) 的收入按細分市場或地理位置如何劃分？



BICO Group AB (publ) 是否盈利？



BICO Group AB (publ) 有負債嗎？



BICO Group AB (publ) 的流通股有多少？



關鍵數據

前收市價

開盤價

當日範圍

$2 - $2

52週區間

$1.97 - $4.21

交易量

300

平均成交量

336

每股盈餘 (TTM)

-1.93

股息收益率

市值

$138.1M

什麼是 BICO GROUP AB？

BICO Group AB engages in the provision of technologies, products, and services to create, understand, and master biology. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 586 full-time employees. The company went IPO on 2016-11-03. The firm focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The firm develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.

功能特性

交易策略